Fig. 6From: Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancerCumulative incidence of radiation pneumonitis of grade 2 or more according to lung V20 level. Lung V20: percentage of lung volume exceeding 20Â GyBack to article page